論文

査読有り
2022年8月3日

Biomarkers Predictive of Distant Disease-free Survival Derived from Diffusion-weighted Imaging of Breast Cancer.

Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine
  • Maya Honda
  • ,
  • Mami Iima
  • ,
  • Masako Kataoka
  • ,
  • Yasuhiro Fukushima
  • ,
  • Rie Ota
  • ,
  • Akane Ohashi
  • ,
  • Masakazu Toi
  • ,
  • Yuji Nakamoto

記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.2463/mrms.mp.2022-0060

PURPOSE: To investigate whether intravoxel incoherent motion (IVIM) and/or non-Gaussian diffusion parameters are associated with distant disease-free survival (DDFS) in patients with invasive breast cancer. METHODS: From May 2013 to March 2015, 101 patients (mean age 60.0, range 28-88) with invasive breast cancer were evaluated prospectively. IVIM parameters (flowing blood volume fraction [fIVIM] and pseudodiffusion coefficient [D*]) and non-Gaussian diffusion parameters (theoretical apparent diffusion coefficient [ADC] at a b value of 0 s/mm2 [ADC0] and kurtosis [K]) were estimated using a diffusion-weighted imaging series of 16 b values up to 2500 s/mm2. Shifted ADC values (sADC200-1500) and standard ADC values (ADC0-800) were also calculated. The Kaplan-Meier method was used to generate survival analyses for DDFS, which were compared using the log-rank test. Univariable Cox proportional hazards models were used to assess any associations between each parameter and distant metastasis-free survival. RESULTS: The median observation period was 80 months (range, 35-92 months). Among the 101 patients, 12 (11.9%) developed distant metastasis, with a median time to metastasis of 79 months (range, 10-92 months). Kaplan-Meier analysis showed that DDFS was significantly shorter in patients with K > 0.98 than in those with K ≤ 0.98 (P = 0.04). Cox regression analysis showed a marginal statistical association between K and distant metastasis-free survival (P = 0.05). CONCLUSION: Non-Gaussian diffusion may be associated with prognosis in invasive breast cancer. A higher K may be a marker to help identify patients at an elevated risk of distant metastasis, which could guide subsequent treatment.

リンク情報
DOI
https://doi.org/10.2463/mrms.mp.2022-0060
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/35922924
ID情報
  • DOI : 10.2463/mrms.mp.2022-0060
  • PubMed ID : 35922924

エクスポート
BibTeX RIS